Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $322.00 |
|---|---|
| Enterprise Value | $-3,200,747.00 |
| Earnings per Share | $248.12 |
| Beta | 1.12 |
| Outstanding Shares | 1,000 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -0.27 |
| Enterprise Value to EBIT | -2.11 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | -1.02 |
| Debt to Equity | 0.12 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 8.80%▼ 16496.00% |
|---|---|
| Total Invested | $46▼ 99.96% |
| Investors Holding | 3▼ 11.00% |
Black Titan Corp. was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. It intends to explore and identify viable business opportunities. The company was founded on July 11, 2024 and is headquartered in Petaling Jaya, Malaysia.
Stockcircle tracks 2 top investors with a current 13F position in Black Titan. Holdings come from the latest quarterly 13F filings filed with the SEC.
In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.